Therefore, whether the relationship between the position of the 389 β1-AR gene variant and the response to β-AR-blockers in patients with heart failure13-15 is in part attributed to a relationship between genotype and an increased risk for the development, severity or progression of heart failure is still uncertain. Here, ADRB1 is linked to heart failure.